These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 22446942)
1. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma. Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188 [TBL] [Abstract][Full Text] [Related]
4. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038 [TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients. Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z Digestion; 2012; 86(4):329-37. PubMed ID: 23207161 [TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453 [TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours. Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876 [TBL] [Abstract][Full Text] [Related]
8. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection. Chen RX; Xia YH; Cui JF; Xue TC; Ye SL J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235 [TBL] [Abstract][Full Text] [Related]
9. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003 [TBL] [Abstract][Full Text] [Related]
11. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma. Wang F; Jing X; Li G; Wang T; Yang B; Zhu Z; Gao Y; Zhang Q; Yang Y; Wang Y; Wang P; Du Z Liver Int; 2012 Apr; 32(4):644-55. PubMed ID: 22118340 [TBL] [Abstract][Full Text] [Related]
12. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540 [TBL] [Abstract][Full Text] [Related]
13. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection. Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524 [TBL] [Abstract][Full Text] [Related]
14. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related]
15. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival. Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053 [TBL] [Abstract][Full Text] [Related]
16. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Petersen RP; Campa MJ; Sperlazza J; Conlon D; Joshi MB; Harpole DH; Patz EF Cancer; 2006 Dec; 107(12):2866-72. PubMed ID: 17099880 [TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma]. Li SP; Peng QQ; Ding T; Xu J; Zhang CQ; Feng KT; Li JQ Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):523-7. PubMed ID: 19062720 [TBL] [Abstract][Full Text] [Related]
18. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Gao Q; Zhou J; Wang XY; Qiu SJ; Song K; Huang XW; Sun J; Shi YH; Li BZ; Xiao YS; Fan J Ann Surg Oncol; 2012 Feb; 19(2):455-66. PubMed ID: 21792513 [TBL] [Abstract][Full Text] [Related]
19. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer. Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941 [TBL] [Abstract][Full Text] [Related]
20. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]